XERESE DIN 02404044
Health Canada record
| Active ingredient(s) | ACYCLOVIR 5 %; HYDROCORTISONE 1 % |
|---|---|
| Dosage form | Cream |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D06BB53 ACICLOVIR, COMBINATIONS |
| Original market date | 26-Jul-2013 |
| Current status date | 30-Dec-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bausch Health Companies Inc. — licence 101880, currently licensed, last inspection rating C (2026-06-01).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ACYCLOVIR
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02197405 | ACYCLOVIR | APOTEX INC | Tablet | ACYCLOVIR 200 MG | Approved |
| 02197421 | ACYCLOVIR | APOTEX INC | Tablet | ACYCLOVIR 800 MG | Approved |
| 02197413 | ACYCLOVIR | APOTEX INC | Tablet | ACYCLOVIR 400 MG | Approved |
| 02207656 | APO-ACYCLOVIR | APOTEX INC | Tablet | ACYCLOVIR 800 MG | Marketed |
| 02207621 | APO-ACYCLOVIR | APOTEX INC | Tablet | ACYCLOVIR 200 MG | Marketed |
| 02207648 | APO-ACYCLOVIR | APOTEX INC | Tablet | ACYCLOVIR 400 MG | Marketed |
| 02477130 | APO-ACYCLOVIR OINTMENT | APOTEX INC | Ointment | ACYCLOVIR 5 % | Marketed |
| 02524716 | MINT-ACYCLOVIR | MINT PHARMACEUTICALS INC | Tablet | ACYCLOVIR 400 MG | Marketed |
| 02524724 | MINT-ACYCLOVIR | MINT PHARMACEUTICALS INC | Tablet | ACYCLOVIR 800 MG | Marketed |
| 02524708 | MINT-ACYCLOVIR | MINT PHARMACEUTICALS INC | Tablet | ACYCLOVIR 200 MG | Marketed |
| 02560437 | MINT-ACYCLOVIR OINTMENT | MINT PHARMACEUTICALS INC | Ointment | ACYCLOVIR 5 % | Approved |
| 02242784 | MYLAN-ACYCLOVIR | MYLAN PHARMACEUTICALS ULC | Tablet | ACYCLOVIR 200 MG | Marketed |
| 02242464 | MYLAN-ACYCLOVIR | MYLAN PHARMACEUTICALS ULC | Tablet | ACYCLOVIR 800 MG | Marketed |
| 02242463 | MYLAN-ACYCLOVIR | MYLAN PHARMACEUTICALS ULC | Tablet | ACYCLOVIR 400 MG | Marketed |
| 02522306 | TARO-ACYCLOVIR | TARO PHARMACEUTICALS INC | Ointment | ACYCLOVIR 5 % | Marketed |
| 02285959 | TEVA-ACYCLOVIR | TEVA CANADA LIMITED | Tablet | ACYCLOVIR 200 MG | Marketed |
| 02285967 | TEVA-ACYCLOVIR | TEVA CANADA LIMITED | Tablet | ACYCLOVIR 400 MG | Marketed |
| 02285975 | TEVA-ACYCLOVIR | TEVA CANADA LIMITED | Tablet | ACYCLOVIR 800 MG | Marketed |
| 00569771 | ZOVIRAX | BAUSCH HEALTH, CANADA INC. | Ointment | ACYCLOVIR 5 % | Marketed |
| 02039524 | ZOVIRAX | BAUSCH HEALTH, CANADA INC. | Cream | ACYCLOVIR 5 % | Marketed |
| 02286556 | ACYCLOVIR | SANIS HEALTH INC | Tablet | ACYCLOVIR 200 MG | Cancelled Post Market |
| 02286572 | ACYCLOVIR | SANIS HEALTH INC | Tablet | ACYCLOVIR 800 MG | Cancelled Post Market |
| 02286564 | ACYCLOVIR | SANIS HEALTH INC | Tablet | ACYCLOVIR 400 MG | Cancelled Post Market |
| 02237541 | ACYCLOVIR-200 | PRO DOC LIMITEE | Tablet | ACYCLOVIR 200 MG | Cancelled Post Market |
| 02237542 | ACYCLOVIR-400 | PRO DOC LIMITEE | Tablet | ACYCLOVIR 400 MG | Cancelled Post Market |
| 02237543 | ACYCLOVIR-800 | PRO DOC LIMITEE | Tablet | ACYCLOVIR 800 MG | Cancelled Post Market |
| 02229708 | ALTI-ACYCLOVIR - 400MG | ALTIMED PHARMA INC. | Tablet | ACYCLOVIR 400 MG | Cancelled Post Market |
| 02229709 | ALTI-ACYCLOVIR - 800MG | ALTIMED PHARMA INC. | Tablet | ACYCLOVIR 800 MG | Cancelled Post Market |
| 02229707 | ALTI-ACYCLOVIR - TAB 200MG | ALTIMED PHARMA INC. | Tablet | ACYCLOVIR 200 MG | Cancelled Post Market |
| 02367513 | NTP-ACYCLOVIR | TEVA CANADA LIMITED | Tablet | ACYCLOVIR 200 MG | Cancelled Pre Market |
| 02367521 | NTP-ACYCLOVIR | TEVA CANADA LIMITED | Tablet | ACYCLOVIR 400 MG | Cancelled Pre Market |
| 02367548 | NTP-ACYCLOVIR | TEVA CANADA LIMITED | Tablet | ACYCLOVIR 800 MG | Cancelled Pre Market |
| 02078627 | RATIO-ACYCLOVIR | TEVA CANADA LIMITED | Tablet | ACYCLOVIR 200 MG | Cancelled Post Market |
| 02078635 | RATIO-ACYCLOVIR | TEVA CANADA LIMITED | Tablet | ACYCLOVIR 400 MG | Cancelled Post Market |
| 02078651 | RATIO-ACYCLOVIR | TEVA CANADA LIMITED | Tablet | ACYCLOVIR 800 MG | Cancelled Post Market |
| 02470098 | SITAVIG | EPI HEALTH, LLC | Tablet | ACYCLOVIR 50 MG | Cancelled (Unreturned Annual) |
| 00886157 | ZOVIRAX | GLAXOSMITHKLINE INC | Suspension | ACYCLOVIR 200 MG | Cancelled Post Market |
| 01911627 | ZOVIRAX 400 | GLAXOSMITHKLINE INC | Tablet | ACYCLOVIR 400 MG | Cancelled Post Market |
| 01911635 | ZOVIRAX 800 | GLAXOSMITHKLINE INC | Tablet | ACYCLOVIR 800 MG | Cancelled Post Market |
| 00590924 | ZOVIRAX CAP 200MG | GLAXO WELLCOME INC. | Capsule | ACYCLOVIR 200 MG | Cancelled Post Market |
| 00634506 | ZOVIRAX TAB 200MG | GLAXOSMITHKLINE INC | Tablet | ACYCLOVIR 200 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 24903 | 2020-12-30 | New Drug Submission (NDS) | CHANGE IN PRODUCT OWNERSHIP |
| 14249 | 2013-03-26 | New Drug Submission (NDS) |
International API supply for ACYCLOVIR
44 active FDA Drug Master Files.
Request a quote for XERESE